Funding for this research was provided by:
National Natural Science Foundation of China (71473130)
Article History
Received: 13 February 2018
Accepted: 4 July 2018
First Online: 20 July 2018
Ethics approval and consent to participate
: The ethical approval for the project was granted by the Ethics Committee of Nanjing Medical University (No. (2015) 300). This approval permits the project to conduct questionnaire surveys for patients and medical professionals, as well as in-depth interviews and panel discussions. A supplementary ethical approval for testing patients’ blood glucose and glycosylated haemoglobin (HbA1C), as well as for reading patient journals, has also been approved. Any modifications to this protocol which may impact on the conduct of the study, potential benefit of the patient or may affect patient safety (such as study objectives, study design, patient population, study procedures, or significant administrative aspects) will be strictly reviewed and agreed by the Ethics Committee of Nanjing Medical University. Written informed consent was received by each participant, and they have been informed that they can quite the study at any time by informing the research team. The informed consent has been reviewed and approved by the Ethics Committee of Nanjing Medical University.
: Not applicable.
: The authors declare that they have no competing interests. The project was peer reviewed during the application process and funding received in competition.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.